156 related articles for article (PubMed ID: 37668862)
1. Nanoparticle (NP)-mediated APOC1 silencing to inhibit MAPK/ERK and NF-κB pathway and suppress breast cancer growth and metastasis.
Liu S; Zhang F; Liang Y; Wu G; Liu R; Li X; Saw PE; Yang Z
Sci China Life Sci; 2023 Nov; 66(11):2451-2465. PubMed ID: 37668862
[TBL] [Abstract][Full Text] [Related]
2. The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway.
Zhang H; Wang Y; Liu C; Li W; Zhou F; Wang X; Zheng J
Pathol Res Pract; 2022 Jan; 229():153746. PubMed ID: 34952429
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Cui Y; Miao C; Hou C; Wang Z; Liu B
Front Oncol; 2020; 10():1436. PubMed ID: 32974161
[No Abstract] [Full Text] [Related]
4. Overexpression of Apolipoprotein C1 (APOC1) in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance.
Xiao H; Xu Y
Med Sci Monit; 2021 Feb; 27():e929347. PubMed ID: 33591959
[TBL] [Abstract][Full Text] [Related]
5. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis.
Cao X; Wu B; Guo S; Zhong W; Zhu S; Zhang Z; Gu L; Li H
Pathol Oncol Res; 2023; 29():1610976. PubMed ID: 36969562
[No Abstract] [Full Text] [Related]
6. ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3.
Li YL; Wu LW; Zeng LH; Zhang ZY; Wang W; Zhang C; Lin NM
Oncogene; 2020 Sep; 39(39):6203-6217. PubMed ID: 32826950
[TBL] [Abstract][Full Text] [Related]
7. Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis.
Ren L; Yi J; Yang Y; Li W; Zheng X; Liu J; Li S; Yang H; Zhang Y; Ge B; Zhang S; Fu W; Dong D; Du G; Wang X; Wang J
Pharmacol Res; 2022 Sep; 183():106376. PubMed ID: 35914680
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
Ren H; Chen Z; Yang L; Xiong W; Yang H; Xu K; Zhai E; Ding L; He Y; Song X
Cancer Manag Res; 2019; 11():4917-4930. PubMed ID: 31213910
[No Abstract] [Full Text] [Related]
9. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis.
Bist P; Leow SC; Phua QH; Shu S; Zhuang Q; Loh WT; Nguyen TH; Zhou JB; Hooi SC; Lim LH
Oncogene; 2011 Jul; 30(28):3174-85. PubMed ID: 21383699
[TBL] [Abstract][Full Text] [Related]
10. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles (NPs)-mediated lncBCMA silencing to promote eEF1A1 ubiquitination and suppress breast cancer growth and metastasis.
Yang K; Xu L; Xu Y; Shen Q; Qin T; Yu Y; Nie Y; Yao H; Xu X
Acta Pharm Sin B; 2023 Aug; 13(8):3489-3502. PubMed ID: 37655325
[TBL] [Abstract][Full Text] [Related]
13. ApoC1 promotes glioma metastasis by enhancing epithelial-mesenchymal transition and activating the STAT3 pathway.
Liang R; Zhang G; Xu W; Liu W; Tang Y
Neurol Res; 2023 Mar; 45(3):268-275. PubMed ID: 36302088
[TBL] [Abstract][Full Text] [Related]
14. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
Wang N; Liu W; Zheng Y; Wang S; Yang B; Li M; Song J; Zhang F; Zhang X; Wang Q; Wang Z
Cell Death Dis; 2018 Aug; 9(9):880. PubMed ID: 30158589
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein C1 promotes tumor progression in gastric cancer.
Gu Q; Zhan T; Guan X; Lai C; Lu NA; Wang G; Xu L; Gao X; Zhang J
Oncol Res; 2023; 31(3):287-297. PubMed ID: 37305389
[TBL] [Abstract][Full Text] [Related]
16. Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells.
Qin B; Cheng K
Breast Cancer Res; 2010; 12(5):R74. PubMed ID: 20863366
[TBL] [Abstract][Full Text] [Related]
17. Micellar nanoparticles inhibit the postoperative inflammation, recurrence and pulmonary metastasis of 4T1 breast cancer by blocking NF-κB pathway and promoting MDSCs depletion.
Lu Z; Ma L; Mei L; Ren K; Li M; Zhang L; Liu X; He Q
Int J Pharm; 2022 Nov; 628():122303. PubMed ID: 36265660
[TBL] [Abstract][Full Text] [Related]
18. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
19. Expression of apolipoprotein C1 in clear cell renal cell carcinoma: An oncogenic gene and a prognostic marker.
Wang HJ; Ma YX; Wang AH; Jiang YS; Jiang XZ
Kaohsiung J Med Sci; 2021 May; 37(5):419-426. PubMed ID: 33305507
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer.
Yi J; Ren L; Wu J; Li W; Zheng X; Du G; Wang J
Ann Transl Med; 2019 Aug; 7(16):380. PubMed ID: 31555694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]